Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
QML Pathology is one of Australia's leading comprehensive medical laboratory and pathology services, operating primarily in Queensland and northern New Suth Wales. With a history spanning nearly a century, QML Pathology offers a wide range of diagnostic testing services to doctors, specialists, and hospitals, as well as directly to patients through its extensive network of collection centres. They are committed to providing accurate and timely results to support patient care and are part of the Healius Limited network of healthcare companies.
Serves as the central laboratory and primary operational hub for QML Pathology, conducting a vast array of diagnostic tests, research, and providing administrative support for its network.
State-of-the-art automated laboratory equipment, specialized molecular and genetic testing facilities, and a significant logistics operation for efficient sample transport and management across a wide geographical area.
A professional environment focused on scientific excellence, precision, patient confidentiality, and continuous improvement. Emphasizes teamwork among medical, scientific, technical, and support staff to ensure high-quality diagnostic services.
The Murarrie facility is a cornerstone of QML Pathology's operations, enabling the processing of millions of tests annually. It plays a critical role in the healthcare system of Queensland and Northern NSW by providing timely and accurate diagnostic information essential for patient treatment and public health.
QML Pathology's operations are primarily concentrated within Australia, with a strong presence in Queensland and northern New South Wales. It does not have a direct international operational presence under the QML Pathology brand. As a key part of Healius Limited, a major Australian publicly listed healthcare company, it contributes to Healius's national footprint in diagnostics and healthcare services.
11 Riverview Place
Murarrie
QLD
Australia
Address: Cairns Day Surgery, Ground Floor, 162-172 McLeod Street, Cairns QLD 4870 (Example of a significant regional lab and collection center)
To deliver timely, accurate, and accessible diagnostic services to the Cairns and Far North Queensland communities, reducing the need for samples to be sent to more distant central labs for all tests and improving turnaround times for critical results.
Address: Robina Hospital, Block C, Level 1, 2 Bayberry Lane, Robina QLD 4226 (Example of a hospital co-located facility)
To offer integrated pathology services within a key healthcare hub on the Gold Coast, ensuring rapid diagnostic support for hospital patients and convenient access for the surrounding population.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, QML Pathology' leadership includes:
QML Pathology has been backed by several prominent investors over the years, including:
Healius, the parent company of QML Pathology, has experienced notable executive changes in the past 12-18 months, including the appointment of a new Group CEO and a new CFO, aimed at strengthening its leadership and strategic direction during a period of portfolio review and market challenges.
Discover the tools QML Pathology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
QML Pathology, as part of Healius, likely utilizes standardized corporate email formats. Common formats in Australian corporations include combinations of first name, last name, and initials.
[first].[last]@qml.com.au (e.g., jane.doe@qml.com.au) or [first_initial][last]@qml.com.au (e.g., jdoe@qml.com.au)
Format
sample.contact@qml.com.au
Example
70%
Success rate
Healius Investor Centre / ASX Announcements • February 22, 2024
Healius Limited (ASX:HLS), parent company of QML Pathology, announced its financial results for the half-year ending December 31, 2023. The pathology division demonstrated revenue growth, attributed to increased testing volumes and operational efficiencies. This performance underscores the essential nature of diagnostic services provided by QML Pathology....more
Healius Investor Centre / ASX Announcements • December 13, 2023
Healius Limited confirmed an agreement to sell its Montserrat Day Hospitals business to Nexus Hospitals. This divestment is part of Healius's strategy to simplify its portfolio and focus on its core businesses of pathology (including QML Pathology) and imaging, aiming to strengthen its market position in these key diagnostic areas....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including QML Pathology, are just a search away.